Cargando…
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
Accurate recurrence risk assessment in hormone receptor positive, HER2/neu negative breast cancer is critical to plan precise therapy. CanAssist Breast (CAB) assesses recurrence risk based on tumor biology using artificial intelligence-based approach. We report CAB risk assessment correlating with d...
Autores principales: | Chandra Doval, Dinesh, Mehta, Anurag, Somashekhar, S.P., Gunda, Aparna, Singh, Gurpreet, Bal, Amanjit, Khare, Siddhant, Prakash V Serkad, Chandra, Adinarayan, Manjula, Krishnamoorthy, Naveen, Vijay, Devanhalli Govinda, Anantakrishnan, Radha, Bhattacharyya, G.S., Bakre, Manjiri M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187842/ https://www.ncbi.nlm.nih.gov/pubmed/34098459 http://dx.doi.org/10.1016/j.breast.2021.05.007 |
Ejemplares similares
-
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
por: Gunda, Aparna, et al.
Publicado: (2022) -
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
por: Sengupta, Aditya K., et al.
Publicado: (2020) -
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
por: Attuluri, Arun Kumar, et al.
Publicado: (2019) -
CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
por: Sankaran, Satish, et al.
Publicado: (2019) -
Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
por: Bakre, Manjiri M., et al.
Publicado: (2019)